Lourdes
Calvo Martínez
Fundación Jiménez Díaz
Madrid, EspañaPublications in collaboration with researchers from Fundación Jiménez Díaz (3)
2017
2016
-
High proliferation predicts pathological complete response to neoadjuvant chemotherapy in early breast cancer
Oncologist, Vol. 21, Núm. 2, pp. 150-155
2014
-
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: Results from the GEICAM/2006-14 trial
British Journal of Cancer, Vol. 110, Núm. 5, pp. 1139-1147